IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise

Elevated levels of type I interferon (IFN) during pregnancy are associated with intrauterine growth retardation, preterm birth, and fetal demise through mechanisms that are not well understood. A critical step of placental development is the fusion of trophoblast cells into a multinucleated syncytio...

Full description

Saved in:
Bibliographic Details
Published inScience (American Association for the Advancement of Science) Vol. 365; no. 6449; pp. 176 - 180
Main Authors Buchrieser, Julian, Degrelle, Séverine A, Couderc, Thérèse, Nevers, Quentin, Disson, Olivier, Manet, Caroline, Donahue, Daniel A, Porrot, Françoise, Hillion, Kenzo-Hugo, Perthame, Emeline, Arroyo, Marlene V, Souquere, Sylvie, Ruigrok, Katinka, Dupressoir, Anne, Heidmann, Thierry, Montagutelli, Xavier, Fournier, Thierry, Lecuit, Marc, Schwartz, Olivier
Format Journal Article
LanguageEnglish
Published United States The American Association for the Advancement of Science 12.07.2019
American Association for the Advancement of Science (AAAS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Elevated levels of type I interferon (IFN) during pregnancy are associated with intrauterine growth retardation, preterm birth, and fetal demise through mechanisms that are not well understood. A critical step of placental development is the fusion of trophoblast cells into a multinucleated syncytiotrophoblast (ST) layer. Fusion is mediated by syncytins, proteins deriving from ancestral endogenous retroviral envelopes. Using cultures of human trophoblasts or mouse cells, we show that IFN-induced transmembrane proteins (IFITMs), a family of restriction factors blocking the entry step of many viruses, impair ST formation and inhibit syncytin-mediated fusion. Moreover, the IFN inducer polyinosinic:polycytidylic acid promotes fetal resorption and placental abnormalities in wild-type but not in deleted mice. Thus, excessive levels of IFITMs may mediate the pregnancy complications observed during congenital infections and other IFN-induced pathologies.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0036-8075
1095-9203
DOI:10.1126/science.aaw7733